Northern Trust’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,250,239
Closed -$4.25M 4344
2018
Q3
$4.25M Buy
1,250,239
+60,096
+5% +$204K ﹤0.01% 2779
2018
Q2
$4.48M Buy
1,190,143
+96,580
+9% +$363K ﹤0.01% 2736
2018
Q1
$4.47M Sell
1,093,563
-10,485
-0.9% -$42.9K ﹤0.01% 2649
2017
Q4
$5.13M Sell
1,104,048
-26,873
-2% -$125K ﹤0.01% 2588
2017
Q3
$8.03M Buy
1,130,921
+41,061
+4% +$292K ﹤0.01% 2331
2017
Q2
$7.88M Buy
1,089,860
+70,420
+7% +$509K ﹤0.01% 2320
2017
Q1
$6.28M Buy
1,019,440
+62,298
+7% +$384K ﹤0.01% 2417
2016
Q4
$5.61M Buy
957,142
+4,926
+0.5% +$28.9K ﹤0.01% 2474
2016
Q3
$5.06M Sell
952,216
-2,181
-0.2% -$11.6K ﹤0.01% 2511
2016
Q2
$6.32M Sell
954,397
-216,130
-18% -$1.43M ﹤0.01% 2313
2016
Q1
$5.47M Buy
1,170,527
+11,109
+1% +$51.9K ﹤0.01% 2355
2015
Q4
$5.86M Buy
1,159,418
+28,344
+3% +$143K ﹤0.01% 2369
2015
Q3
$3.98M Buy
1,131,074
+30,590
+3% +$108K ﹤0.01% 2584
2015
Q2
$11M Sell
1,100,484
-13,240
-1% -$132K ﹤0.01% 2008
2015
Q1
$14.2M Buy
1,113,724
+106,351
+11% +$1.35M ﹤0.01% 1843
2014
Q4
$14.3M Sell
1,007,373
-34,369
-3% -$486K ﹤0.01% 1793
2014
Q3
$14.3M Sell
1,041,742
-2,089
-0.2% -$28.7K ﹤0.01% 1775
2014
Q2
$16.1M Sell
1,043,831
-124,747
-11% -$1.92M 0.01% 1701
2014
Q1
$19.9M Buy
1,168,578
+5,035
+0.4% +$85.8K 0.01% 1572
2013
Q4
$15.1M Buy
1,163,543
+26,091
+2% +$338K ﹤0.01% 1768
2013
Q3
$11.5M Sell
1,137,452
-5,898
-0.5% -$59.5K ﹤0.01% 1930
2013
Q2
$8.54M Buy
+1,143,350
New +$8.54M ﹤0.01% 2036